Zobrazeno 101 - 110
of 4 256
pro vyhledávání: ''
Autor:
Ying-Jun Chang, Qiao-Zhu Zeng, Ye-Jun Wu, Lan-Ping Xu, Qian Jiang, Yun He, Xiao-Hui Zhang, Yi Liu, He-Bing Zhou, Jing-Wen Wang, Hao Jiang, Qiu-Sha Huang, Hui Liu, Jia Feng, Wen-Sheng Wang, Xiao-Jun Huang, Xiao-Lu Zhu, Hai-Xia Fu
Publikováno v:
Blood. 139(3)
The study aimed to compare the efficacy and safety of all-trans retinoic acid (ATRA) plus low-dose rituximab (LD-RTX) with LD-RTX monotherapy in corticosteroid-resistant or relapsed immune thrombocytopenia (ITP) patients. Recruited patients were rand
Autor:
Mark R. Schleiss
Publikováno v:
Blood
Decreased cytomegalovirus (CMV)-specific immunity after hematopoietic cell transplantation (HCT) is associated with late CMV reactivation and increased mortality. Whether letermovir prophylaxis-associated reduction in viral exposure influences CMV-sp
Autor:
Thomas L. Ortel, Gowthami M. Arepally
Publikováno v:
Blood
The development of vaccines to fight COVID-19 has been a remarkable medical achievement. However, this global immunization effort has been complicated by a rare vaccine-related outcome characterized by thrombocytopenia and thrombosis in association w
Publikováno v:
Blood. 136:1783-1785
Autor:
Marta Derecka
Publikováno v:
Blood. 138(7)
Autor:
John W. Semple, Rick Kapur
Publikováno v:
Blood
Blood, 138(8), 591-592. American Society of Hematology
Blood, 138(8), 591-592. American Society of Hematology
New treatment options are required for patients with refractory immune thrombocytopenia (ITP), a disease in which immune tolerance has been lost due to reduced regulatory T-cell (Treg) activity. Han et al demonstrate that the hypomethylating agent de
Autor:
Joseph P. McGuirk, Ran Reshef, Michael R. Grunwald, Mary Eapen, Natasha Kekre, Rizwan Romee, Ephraim J. Fuchs, Christopher G. Kanakry, Mahasweta Gooptu, Robert J. Soiffer, Claudio G. Brunstein, Nilanjan Ghosh, Mark A. Schroeder, Saurabh Chhabra, Yoshihiro Inamoto, Ian McNiece, Filippo Milano, Dipenkumar Modi, Rohtesh S. Mehta, Monzr M. Al Malki, Joseph H. Antin, Edmund K. Waller, Marco Mielcarek, Andrew St. Martin, Christopher Bredeson, Scott R. Solomon, Mukta Arora
Publikováno v:
Blood
Post transplant cyclophosphamide (PTCy) graft-versus-host disease (GVHD) prophylaxis has allowed haploidentical (Haplo) transplantation to be performed with results similar to that after matched unrelated donor (MUD) transplantation with traditional
Autor:
Iskra Pusic, Steven Z. Pavletic, John P. Galvin, Amandeep Salhotra, Zhongming Yang, Dianna S. Howard, Madan Jagasia, Ayman Saad, Wanxing Chai-Ho, Bruce R. Blazar, Aaron C Logan, Amelia Langston, Corey Cutler, Trent P Wang, Jonathan Ieyoub, Sally Arai, Marcello Rotta, Mukta Arora, Jane L. Liesveld, Asaf Alavi, David Eiznhamer, Mark B. Juckett, Annie Im, Aravind Ramakrishnan, Behyar Zoghi, Sunil Abhyankar, John J. Ryan, Nirav N. Shah, Stephanie J. Lee, Laurie S. Green, Zachariah DeFilipp, Heidi Krenz, Rohtesh S. Mehta, Harlan Waksal, Sanjay K. Aggarwal, Carlos R. Bachier, Levanto Schachter, Aleksandr Lazaryan, Olivier Schueller
Publikováno v:
Blood
Introduction: Belumosudil (KD025) is a novel oral selective rho-associated coiled-coil kinase 2 (ROCK2) inhibitor specifically designed for the treatment of cGVHD, an immune-mediated inflammatory and fibrotic disorder. In a previous dose-finding stud
Autor:
Andreas Tiede, Heiner Wedemeyer, Sonja Werwitzke, Frank Gf Donnerstag, Arnold Ganser, Ulrich J. Sachs, Andreas Czwalinna, Günter U. Höglinger, Benjamin Maasoumy, Joachim K. Krauss, Karin Weißenborn, Rolf Bikker
Publikováno v:
Blood
We report 5 cases of prothrombotic immune thrombocytopenia after exposure to the ChAdOx1 vaccine (AZD1222, Vaxzevria) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients presented 5 to 11 days after first vaccination. The s
Autor:
Simon J. Harrison, Jeremy Er
Publikováno v:
Blood. 138(2)